The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global nanorobotics market reached a value of US$ 5.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.0 Billion by 2027, exhibiting a CAGR of 11.75% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Nanorobotics refers to an emerging technology that helps to create machines or robots that have components around the scale of a nanometer. These robots are known as nanorobots and can be injected into patients for performing diagnosis or providing treatment at the cellular level. They can also be used in pharmacokinetics, disease monitoring, targeting drug delivery in cancer therapeutics and improving the effectiveness and efficiency of healthcare. Besides this, they are utilized for assembling and maintaining sophisticated systems.
Extensive applications of nanorobotics in the medical industry are one of the primary factors driving the market growth. Recent research has suggested that nanorobots can serve as antibodies or antiviral agents in patients with compromised immunity or diseases that do not respond to conventional treatment methods. As a result, nanorobots are being used in gene therapy and cancer detection and treatment. They are also being employed in various dentistry procedures and act as ancillary devices for processing different chemical reactions in the affected organs. Furthermore, nanorobots are utilized for monitoring and controlling glucose levels in diabetic patients. Some of the other medical applications of nanorobots that are strengthening the nanorobotics market growth include repairing damaged tissues and unblocking arteries affected by plaques. Apart from this, governments of several countries are extending their support by increasing investments in nanorobotics. Consequently, the leading players are increasing their focus on research and development (R&D) activities to introduce technological advancements in molecular robotics.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nanorobotics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.
Breakup by Type:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Bruker Corporation, EV Group, Ginkgo Bioworks Inc., Imina Technologies SA, JEOL Ltd., Kleindiek Nanotechnik GmbH, Nanonics Imaging Limited, Oxford Instruments plc, Synthace Limited, Thermo Fisher Scientific Inc., Toronto Nano Instrumentation Inc. and Zymergen Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Bruker Corporation, EV Group, Ginkgo Bioworks Inc., Imina Technologies SA, JEOL Ltd., Kleindiek Nanotechnik GmbH, Nanonics Imaging Limited, Oxford Instruments plc, Synthace Limited, Thermo Fisher Scientific Inc., Toronto Nano Instrumentation Inc. and Zymergen Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at